Incidence of Idiopathic Intracranial Hypertension in Individuals With Gonadotropin-Releasing Hormone Analogue Treatment for Gender Dysphoria in Sweden

Georgios Karamanis; Thomas Frisell; Mats Holmberg; Maria Halldin; Sara Sylvén; Alkistis Skalkidou; Fotios C Papadopoulos

doi:10.1001/jamapediatrics.2023.0656

Incidence of Idiopathic Intracranial Hypertension in Individuals With Gonadotropin-Releasing Hormone Analogue Treatment for Gender Dysphoria in Sweden

JAMA Pediatr. 2023 Jul 1;177(7):726-727. doi: 10.1001/jamapediatrics.2023.0656.

Authors

Georgios Karamanis¹, Thomas Frisell², Mats Holmberg³, Maria Halldin⁴, Sara Sylvén¹, Alkistis Skalkidou⁵, Fotios C Papadopoulos¹

Affiliations

¹ Department of Medical Sciences, Psychiatry, Uppsala University Hospital, Uppsala, Sweden.
² Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
³ ANOVA, Karolinska University Hospital, Stockholm, Sweden.
⁴ Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Women's and Children's Health, Obstetrics and Gynecology, Uppsala University, Uppsala, Sweden.

No abstract available

Plain language summary

This cohort study examines the incidence of idiopathic intracranial hypertension (IHH) among individuals in Sweden undergoing gonadotropin-releasing hormone analogue (GnRHa) treatment for gender dysphoria.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Gender Dysphoria* / drug therapy
Gonadotropin-Releasing Hormone
Humans
Incidence
Pseudotumor Cerebri*
Sweden / epidemiology

Substances

Gonadotropin-Releasing Hormone